Fasenra 30 mg /1 ml, Injektionslösung in einer Fertigspritze
7680665820019
CH-66582
Injektionslösung
Associated product:
FASENRA sol inj 30 mg/ml ser pré 1 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
30.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2538.90
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/08/2018
Authorization holder
AstraZeneca AG
6340 Baar
Authorization information
- Swissmedic authorization number
- 66582
- Drug name
- Fasenra, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- R03DX10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 08/06/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 03.04.5.
- Domain
- Human medicine
Package details
- Description (FR)
- FASENRA sol inj 30 mg/ml ser pré 1 ml
- Description (DE)
- FASENRA Inj Lös 30 mg/ml Fertspr 1 ml
- Market launch
- 08/06/2018
- Narcotic (BTM)
- No